Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

EMA advises GSK on Ebola vaccine development plan The European Medicines Agency (EMA) has given scientific advice to GSK on its development plan for an Ebola vaccine.
Drug Research > Drug Delivery > News
Triphase, Celgene extend deal for IV formulation of marizomib and bevacizumab for glioblastoma By PBR Staff Writer
Drug development firm Triphase Accelerator has extended its strategic collaboration with Celgene for a Phase I development program to explore combining an intravenous (IV) formulation of marizomib with bevacizumab in glioblastoma (GBM), an aggressive malignant primary brain tumor.
Drug Research > Drug Delivery > News WCCT Global announces involvement in H1N1 oral vaccine development WCCT Global, a full Service Contract Research Organization headquartered in Southern California announced their involvement in a sentinel clinical trial designed to evaluate safety and immunogenicity signals from a novel oral vaccine for influenza, as opposed to injectable or intranasal vaccines.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
Regulatory Affairs
The burden of regulation imposed by national health system legislation and regulatory authorities is continually growing. NNIT can help you use IT to comply with new and upcoming regulations from drug development and regulatory submissions to post-marketing while ensuring that you can manage your data and improve collaboration across your organisation.
Drug Research > Drug Delivery > Products
Drug Development
Transforming a compound into a drug is a massive investment. An integrated IT strategy across your clinical value chain can maximise this investment and speed up time to market.
Drug Research > Drug Delivery > Products
EMA advises GSK on Ebola vaccine development plan
The European Medicines Agency (EMA) has given scientific advice to GSK on its development plan for an Ebola vaccine.
Drug Research > Drug Delivery > News
Case Stories
NNIT started life as the IT department of an international pharmaceutical company. This has given us an insiders’ understanding of the way the life sciences industry works. Our people are united by a high level of IT expertise coupled with a commitment to deliver the highest level of quality. In short, we go out of our way to make sure your IT processes increase your business efficiency and support your organisational ambitions.
Drug Research > Drug Delivery > Case Studies
Sign up to NNIT’s Newsletter
| By NNIT
Sign up to NNIT’s newsletter and receive inspiration on how IT can create value for life sciences companies. You'll get articles, whitepapers, cases and invitations to webinars. Sign up here: http://www.nnit.com/pages/news.aspx#/
Drug Research > Drug Delivery > White Papers
Triphase, Celgene extend deal for IV formulation of marizomib and bevacizumab for glioblastoma
By PBR Staff Writer
Drug development firm Triphase Accelerator has extended its strategic collaboration with Celgene for a Phase I development program to explore combining an intravenous (IV) formulation of marizomib with bevacizumab in glioblastoma (GBM), an aggressive malignant primary brain tumor.
Drug Research > Drug Delivery > News
WCCT Global announces involvement in H1N1 oral vaccine development
WCCT Global, a full Service Contract Research Organization headquartered in Southern California announced their involvement in a sentinel clinical trial designed to evaluate safety and immunogenicity signals from a novel oral vaccine for influenza, as opposed to injectable or intranasal vaccines.
Drug Research > Drug Delivery > News
Fresenius Kabi launches Kabiven in US
Fresenius Kabi has launched Kabiven (amino acids, electrolytes, dextrose and lipid injectable emulsion) for intravenous use, with immediate availability. Kabiven is a parenteral nutrition (PN) product in a three-chamber bag – the only container of its kind approved in the US.
Drug Research > Drug Delivery > News
Octapharma's Octagam 10% now available for ordering in US
Octapharma USA has announced that Octagam10% [Immune Globulin Intravenous (Human) 10% (100 mg/mL) Liquid Preparation] is available for ordering within the US.
Drug Research > Drug Delivery > News
View all Drug Delivery news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250